Stocktoria
EBR Systems, Inc. EBRCZ
EBR Systems, Inc. (EBRCZ) earns a Piotroski F-score of 2/9 (weak financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $1.6M at a -3015.3% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
How it ranks in Manufacturing · percentile among 2036 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 2/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.607 |
| Retained earnings / assets | -4.137 |
| EBIT / assets | -0.474 |
| Equity / liabilities | 0.357 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| EBRCZ | EBR Systems, Inc. | 2/9 | -12.31 | — | — |
| EMED | Electromedical Technologies, Inc | 4/9 | — | — | — |
| ICU | SeaStar Medical Holding Corp | 3/9 | — | — | — |
| PETV | PetVivo Holdings, Inc. | 2/9 | — | — | — |
| SINT | Sintx Technologies, Inc. | 2/9 | — | — | — |
| FEMY | FEMASYS INC | 2/9 | — | — | — |
| CODX | Co-Diagnostics, Inc. | 1/9 | -16.26 | — | — |
About EBR Systems, Inc.
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. It offers WiSE cardiac resynchronization therapy system, an implantable cardiac pacing system able to provide stimulation to endocardial heart tissue for the correction of heart rhythm conditions without requiring the use of leads; and stimulation of the left ventricular endocardium for cardiac resynchronization therapy (SOLVE-CRT), an investigational device exemption. The company was incorporated in 2003 and is headquartered in Sunnyvale, California.
FAQ
Is EBRCZ financially healthy?
EBR Systems, Inc.'s Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does EBRCZ pay a dividend?
No, EBR Systems, Inc. does not currently pay a dividend.
How profitable is EBRCZ?
In FY2025, EBR Systems, Inc. had a net margin of -3015.3% and a return on equity of -190.6%.
Is EBRCZ a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on EBR Systems, Inc.: a Piotroski F-score of 2/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.